Cluster 2 comprised constipation, dehydration, headache, diarrhea, dizziness, hypoglycemia, sweating, and jaundice
When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities
Chemopreventive role of anthocyanins in atherosclerosis via activation of Nrf2ARE as an indicator and modulator of redox
Due to the pure vitamin C (Ascorbic acid) content, there may be discoloration and changes in odor at high temperatures, so please store in a cool, dark place (or refrigerate) after opening
A comprehensive map of molecular drug targets
Liv Hospitals guidelines are based on the latest research and clinical evidence
